Amy Kupic

1.9k total citations · 1 hit paper
5 papers, 798 citations indexed

About

Amy Kupic is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Dermatology. According to data from OpenAlex, Amy Kupic has authored 5 papers receiving a total of 798 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 1 paper in Dermatology. Recurrent topics in Amy Kupic's work include Bone health and treatments (3 papers), Prostate Cancer Treatment and Research (3 papers) and Cancer Diagnosis and Treatment (2 papers). Amy Kupic is often cited by papers focused on Bone health and treatments (3 papers), Prostate Cancer Treatment and Research (3 papers) and Cancer Diagnosis and Treatment (2 papers). Amy Kupic collaborates with scholars based in United States, Poland and Mexico. Amy Kupic's co-authors include Benjamin Z. Leder, Fred Saad, Narciso Hernández Toriz, Robert Feldman, Teuvo L.J. Tammela, Carsten Goessl, Blair Egerdie, Chunlei Ke, Matthew Smith and Jiří Heráček and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and European Urology Supplements.

In The Last Decade

Amy Kupic

5 papers receiving 760 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer

2009 786 citations Matthew Smith, Blair Egerdie et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy Kupic United States	3	603	347	337	197	175	5	798
Narciso Hernández Toriz Mexico	4	596 1.0×	353 1.0×	337 1.0×	204 1.0×	168 1.0×	6	799
Leo V. Lacerna United States	10	734 1.2×	254 0.7×	361 1.1×	58 0.3×	200 1.1×	13	802
Bijvoet Ol Netherlands	10	515 0.9×	150 0.4×	266 0.8×	171 0.9×	128 0.7×	17	720
T. Taube Finland	12	515 0.9×	162 0.5×	119 0.4×	128 0.6×	201 1.1×	15	620
Lixian Jin United States	8	493 0.8×	118 0.3×	197 0.6×	69 0.4×	195 1.1×	15	559
A. Galid Austria	9	519 0.9×	167 0.5×	113 0.3×	96 0.5×	155 0.9×	27	748
Richard Leff United States	9	529 0.9×	190 0.5×	72 0.2×	52 0.3×	228 1.3×	14	659
W. Dornoff Germany	9	569 0.9×	259 0.7×	126 0.4×	71 0.4×	202 1.2×	15	688
R G Stillwell Australia	6	355 0.6×	103 0.3×	38 0.1×	137 0.7×	68 0.4×	7	549
Evelyn Loyer United States	7	285 0.5×	54 0.2×	39 0.1×	149 0.8×	35 0.2×	11	491

Countries citing papers authored by Amy Kupic

Since Specialization

Citations

This map shows the geographic impact of Amy Kupic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Kupic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Kupic more than expected).

Fields of papers citing papers by Amy Kupic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Kupic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Kupic. The network helps show where Amy Kupic may publish in the future.

Co-authorship network of co-authors of Amy Kupic

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Kupic. A scholar is included among the top collaborators of Amy Kupic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Kupic. Amy Kupic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Bárcenas, Carlos H., Sara A. Hurvitz, Jack A. Di Palma, et al.. (2019). Effect of prophylaxis on neratinib-associated diarrhea and tolerability in patients with HER2+ early-stage breast cancer: Phase II CONTROL trial.. Journal of Clinical Oncology. 37(15_suppl). 548–548. 7 indexed citations

2.

Borkowski, Tomasz, Mitchell R. Smith, Farid Saad, et al.. (2011). C176 PROLONGED BONE METASTASIS-FREE SURVIVAL IN MEN WITH CASTRATE-RESISTANT PROSTATE CANCER RECEIVING DENOSUMAB: RESULTS FROM A PHASE 3, RANDOMISED, DOUBLE-BLIND TRIAL. European Urology Supplements. 10(9). 656–656. 2 indexed citations

3.

Saad, Fred, Matthew R. Smith, Robert E. Coleman, et al.. (2011). Denosumab treatment for prolonging bone metastasis-free survival in men with castrate-resistant prostate cancer. 1. 1 indexed citations

4.

Smith, Matthew, Blair Egerdie, Narciso Hernández Toriz, et al.. (2009). Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer. New England Journal of Medicine. 361(8). 745–755. 786 indexed citations breakdown →

5.

Smith, Matthew Ryan, Blair Egerdie, Robert Feldman, et al.. (2009). 846 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF DENOSUMAB IN MEN RECEIVING ANDROGEN DEPRIVATION THERAPY FOR NON-METASTATIC PROSTATE CANCER. European Urology Supplements. 8(4). 332–332. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact